Updating results…
What is Maestro-03 MBP8298-SP?
Phase III double-blind, placebo controlled multi-center study to evaluate the efficacy and safety of MBP8298 in subjects with secondary progressive multiple sclerosis.
Reported Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Personal research | 1 |  |
See all 1 patient who’ve stopped using Maestro-03 MBP8298-SP
Reported Duration See details about how long patients take this treatment ▼
Stopped Using Maestro-03 MBP8298-SP
A bar graph
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
Reported Adherence, Burden & Cost See details from patient evaluations ▼
Adherence
Taking treatment as prescribed
Adherence of Maestro-03 MBP8298-SP
Always |
1 | 100% |
|
|---|---|---|---|
Usually |
0 | 0% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Maestro-03 MBP8298-SP
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
0 | 0% |
|
A little |
0 | 0% |
|
Not at all |
1 | 100% |
|
Cost
Paid out of pocket
Cost of Maestro-03 MBP8298-SP
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
0 | 0% |
|
< $25 |
1 | 100% |
|
0 helpful marks